Formulation Licenses
Registered finished dosage forms (FDF), transferable tech packages and in-development in-licensing pipelines · delivered per target-market approval pathway
Formulation (FDF)
Ziprasidone Hcl Capsules
Capsules · 20mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB912)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Ziprasidone mesilate for injection
for injection · 20mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB911)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Tiapride Hcl Tablets
Tablets · 100mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB910)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Risperidone Tablets
Tablets · 1mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB909)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Sulpiride Tablets
Tablets · 100mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB908)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Riluzole Tablets
Tablets · 50mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB907)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Risperidone Orally Dispersible Tablets
Tablets · 1mg;2mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB906)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Quetiapine Fumarate Tablets
Tablets · 50mg;100mg;200mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB905)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Penfluridol Tablets
Tablets · 20mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB904)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Olanzapine Tablets
Tablets · 5mg;10mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB903)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Lithium Carbonate Sustained Release
— · 300mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB902)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Gabapentin Capsules
Capsules · 100mg;300mg;400mg;600mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB901)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Duloxetine Hydrochloride Enteric Capsules
Capsules · 30mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB900)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Duloxetine Hydrochloride Enteric-coated Tablets
Tablets · 20mg;30mg;60mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB899)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Carbamazepine Tablet
Tablet · 100mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB898)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Citalopram Hydrobromide Tablets
Tablets · 20mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB897)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Clomipramine Hydrochloride Injection
Injection · 2ml:25mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB896)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Clomipramine Hydrochloride Tablets
Tablets · 10mg;25mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB895)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Clozapine Tablets
Tablets · 25mg;50mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB894)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Clozapine Orally Dispersible Tablets
Tablets · 25mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB893)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Buspirone Hcl Tablets
Tablets · 5mg;10mg;15mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB892)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Aripiprazole Tablets
Tablets · 10mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB891)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Naproxen Sustained Release Capsules
Capsules · 250mg
- Therapy
- Others > Rheumatology
- Status
- Official FDF licensing catalog (UB890)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Ropivacaine Mesylate Injection
Injection · 10ml:89.4mg
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB889)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Penehyclidine Hydrochloride Injection
Injection · 1ml:0.5mg; 1ml:1mg; 2ml:2mg
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB888)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Propofol Injection
Injection · 20ml:0.2g
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB887)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Naloxone Hcl Injection
Injection · 1ml:0.4mg
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB886)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Mivacurium Chloride Injection
Injection · 10ml:20mg;5ml:10mg
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB885)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Flumazenil Injection
Injection · 2ml:0.2mg; 5ml:0.5mg; 10ml:1.0g
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB884)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Etomidate Fat Emulsion Injection
Injection · 10ml:20mg
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB883)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Dexmedetomidine Hydrochloride Injection
Injection · 1ml:0.1mg; 2ml:0.2mg
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB882)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Doxapram Hcl Injection
Injection · 5ml:0.1g
- Therapy
- Respiratory
- Status
- Official FDF licensing catalog (UB881)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Tapentadol Extended Release Tablets
Tablets · 50mg; 100mg; 150mg
- Therapy
- Neurology
- Status
- Official FDF licensing catalog (UB880)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- Germany
Formulation (FDF)
Rivaroxaban Tablets
Tablets · 10mg; 15mg; 20mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB879)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- France, Germany
Formulation (FDF)
Metoprolol Succinate Extended-Release Tablets
Tablets · 23.8mg; 47.5mg; 95mg; 190mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB878)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Fentanyl Citrate Injection
Injection · 0.1mg/2ml; 0.5mg/10ml
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB877)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- Germany, Netherlands, Poland…
Formulation (FDF)
Hydromorphone Hydrochloride Injection
Injection · 2mg/ml;10mg/ml
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB876)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- Germany
Formulation (FDF)
Fospropofol Disodium for Injection
for Injection
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB875)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Remimazolam Besylate for Injection
for Injection · 25mg; 50mg
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB874)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- China
Formulation (FDF)
Parecoxib Sodium for Injection
for Injection · 20mg, 40mg
- Therapy
- Anesthesiology
- Status
- Official FDF licensing catalog (UB873)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- EU, China
Formulation (FDF)
Heparin Sodium Injection
Injection · 1mL:5000iu
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB872)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States, China
Formulation (FDF)
Rivaroxaban Tablets
Tablets · 2.5mg, 10mg, 15mg, 20mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB871)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- EU
Formulation (FDF)
Apixaban Tablets
Tablets · 2.5mg, 5mg
- Therapy
- Cardiovascular
- Status
- Official FDF licensing catalog (UB870)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Sitagliptin Tablets
Tablets · 25mg, 50mg, 100mg
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB869)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Sitagliptin and Metformin ER Tablets
Tablets · 50mg/1000mg, 100mg/1000mg
- Therapy
- Metabolic & Endocrinology
- Status
- Official FDF licensing catalog (UB868)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Sunitinib Capsules
Capsules · 12.5mg, 25mg, 37.5mg, 50mg
- Therapy
- Oncology
- Status
- Official FDF licensing catalog (UB867)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Mycophenolic acid DR Tablets
Tablets · 180mg, 360mg
- Therapy
- Nephrology & Urology
- Status
- Official FDF licensing catalog (UB866)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States
Formulation (FDF)
Guanfacine ER Tablets
Tablets · 1mg, 2mg, 3mg, 4mg
- Therapy
- Others > Psychiatry
- Status
- Official FDF licensing catalog (UB865)
- Registration
- Registered (market rights transferable / DCP·NP per market)
- Markets
- United States